Skip to main content

LOXL1 Antibody (C1)

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-41652

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-41652

Key Product Details

Species Reactivity

Human

Applications

Immunohistochemistry, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2a Kappa Clone # C1

Concentration

1 mg/ml

Product Specifications

Immunogen

Immunized with recombinant Human LOXL1 (Uniprot#: Q08397; Leu369-Ser574 (Uniprot#: Q08397)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2a Kappa

Applications for LOXL1 Antibody (C1)

Application
Recommended Usage

Immunohistochemistry

5-20ug/mL

Western Blot

0.01-2ug/mL
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A or G purified

Formulation

0.01M PBS, pH7.4, 50% glycerol

Preservative

0.05% Proclin 300

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: LOXL1

The LOXL1 gene encodes a member of the lysyl oxidase gene family. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyses the first step in the formation o

Long Name

Lysyl Oxidase like 1

Alternate Names

LOXL, Lysyl Oxidase Homolog 1, Lysyl Oxidase like 1

Gene Symbol

LOXL1

Additional LOXL1 Products

Product Documents for LOXL1 Antibody (C1)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for LOXL1 Antibody (C1)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...